CorMedix (CRMD) Cash from Investing Activities (2010 - 2025)

CorMedix (CRMD) has 12 years of Cash from Investing Activities data on file, last reported at $3.3 million in Q4 2025.

• For the quarter ending Q4 2025, Cash from Investing Activities rose 1185.0% year-over-year to $3.3 million; the trailing twelve-month figure through Dec 2025 stood at -$308.4 million (down 1552.73% YoY), and the FY2025 full-year result was -$308.4 million, down 1552.73% from the prior year.
• Cash from Investing Activities improved to $3.3 million in Q4 2025, from -$291.3 million in the prior quarter.
• In the past five years, Cash from Investing Activities ranged from a high of $8.9 million in Q1 2024 to a low of -$291.3 million in Q3 2025.
• A 5-year average of -$15.9 million and a median of -$256074.5 in 2021 frame the typical range for Cash from Investing Activities.
• Across the five-year window, Cash from Investing Activities soared 32222.08% in 2023 and sank 4708.5% in 2025, its largest moves.
• Tracing CRMD's Cash from Investing Activities over 5 years: stood at -$7.1 million in 2021, then surged by 99.97% to -$1861.0 in 2022, then soared by 32222.08% to $597792.0 in 2023, then slumped by 150.83% to -$303874.0 in 2024, then soared by 1185.0% to $3.3 million in 2025.
• Business Quant data shows CRMD's Cash from Investing Activities at $3.3 million in Q4 2025, -$291.3 million in Q3 2025, and -$20.2 million in Q2 2025.